See more : SalfaCorp S.A. (SALFACORP.SN) Income Statement Analysis – Financial Results
Complete financial analysis of Biotechnologies Assets SA (BST.MC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biotechnologies Assets SA, a leading company in the Biotechnology industry within the Healthcare sector.
- F5, Inc. (0IL6.L) Income Statement Analysis – Financial Results
- NDL Ventures Limited (NDLVENTURE.BO) Income Statement Analysis – Financial Results
- CONFIDENCE FUTURISTIC ENERGETE (CFEL.BO) Income Statement Analysis – Financial Results
- Alleima AB (publ) (ALLEI.ST) Income Statement Analysis – Financial Results
- Tempo Automation Holdings, Inc. (TMPOQ) Income Statement Analysis – Financial Results
Biotechnologies Assets SA (BST.MC)
About Biotechnologies Assets SA
Biotechnologies Assets SA develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.91M | 2.61M | 3.09M | 2.52M | 41.83M | 23.32M | 2.39M | 1.31M | 1.05M | 1.88M | 870.46K | 443.17K | 289.15K | 137.97K |
Cost of Revenue | 450.59K | -20.86K | 49.79K | -196.76K | 15.82M | 8.70M | -889.88K | -1.18M | -686.75K | -735.74K | -449.84K | -489.25K | -499.69K | -260.62K |
Gross Profit | 3.46M | 2.63M | 3.04M | 2.72M | 26.01M | 14.61M | 3.28M | 2.49M | 1.74M | 2.62M | 1.32M | 932.42K | 788.84K | 398.60K |
Gross Profit Ratio | 88.47% | 100.80% | 98.39% | 107.79% | 62.18% | 62.68% | 137.25% | 189.54% | 165.38% | 139.12% | 151.68% | 210.40% | 272.81% | 288.90% |
Research & Development | 0.00 | 18.22K | 20.29K | 47.51K | 39.48K | 94.48K | 126.00K | 219.40K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 458.30K | 605.12K | 900.72K | 354.94K | 3.82M | 4.31M | 284.18K | 973.49K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 38.60K | 14.34K | 52.07K | 32.24K | 78.83K | 210.82K | 5.17K | 9.35K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 496.90K | 619.46K | 952.78K | 387.19K | 3.90M | 4.52M | 289.35K | 982.84K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 343.55K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 840.45K | 4.34M | 4.57M | 3.90M | 31.55M | 28.27M | 3.53M | 3.29M | 2.33M | 2.28M | 1.10M | 1.69M | 1.08M | 879.47K |
Cost & Expenses | 1.25M | 4.32M | 4.62M | 3.70M | 47.37M | 36.98M | 2.64M | 2.12M | 1.64M | 1.55M | 651.84K | 1.21M | 583.69K | 618.84K |
Interest Income | 2.26K | 161.14 | 4.23K | 85.39 | 1.53K | 0.00 | 0.00 | 0.00 | 147.00 | 44.64K | 96.78K | 1.53K | 110.23K | 0.00 |
Interest Expense | 310.97K | 345.45K | 854.67K | 333.36K | 3.27M | 1.23M | 1.01M | 1.26M | 104.72K | 239.29K | 159.73K | 170.08K | 129.59K | 0.00 |
Depreciation & Amortization | 2.47M | 2.15M | 2.03M | 2.21M | 4.30M | 2.73M | 1.33M | 1.23M | 608.50K | 599.60K | 502.89K | 514.47K | 514.64K | 291.18K |
EBITDA | 5.10M | 450.40K | -25.03K | 993.11K | 1.76M | -11.08M | -10.19M | -459.74K | 42.28K | 1.60M | 818.26K | -246.31K | 220.10K | -189.69K |
EBITDA Ratio | 130.46% | 8,151.98% | 0.71% | 39.34% | -3.52% | -47.51% | 44.83% | 29.59% | 1.49% | 51.85% | 94.00% | -55.58% | 76.12% | -137.48% |
Operating Income | 2.65M | 1.73M | -2.07M | -1.21M | -6.71M | -14.95M | -263.82K | -1.67M | -588.95K | 331.60K | 218.62K | -762.31K | -75.23K | -60.49K |
Operating Income Ratio | 67.91% | 66.15% | -67.21% | -47.87% | -16.04% | -64.10% | -11.04% | -127.39% | -56.07% | 17.63% | 25.12% | -172.01% | -26.02% | -43.85% |
Total Other Income/Expenses | -331.66K | -3.77M | -4.98M | -346.05K | -378.89K | -2.08M | -1.04M | -138.72K | -81.99K | 424.67K | -62.98K | -168.55K | -19.36K | -35.41K |
Income Before Tax | 2.32M | -2.04M | -2.91M | -1.55M | -9.99M | -16.81M | -378.65K | -1.81M | -670.94K | 756.27K | 155.64K | -930.86K | -94.59K | -95.90K |
Income Before Tax Ratio | 59.42% | -78.15% | -94.32% | -61.58% | -23.89% | -72.08% | -15.85% | -137.96% | -63.88% | 40.21% | 17.88% | -210.05% | -32.71% | -69.51% |
Income Tax Expense | 748.58K | -98.99K | 103.47K | 150.34K | 89.14K | -90.21K | -266.88K | -582.06K | -478.34K | -437.15K | -317.41K | -588.78K | -402.74K | -649.26K |
Net Income | 1.57M | -1.94M | -3.01M | -8.61M | -10.08M | -16.69M | -73.39K | -1.14M | -192.60K | 1.19M | 473.06K | -342.08K | 308.15K | 553.35K |
Net Income Ratio | 40.27% | -74.35% | -97.65% | -340.91% | -24.10% | -71.60% | -3.07% | -86.55% | -18.34% | 63.46% | 54.35% | -77.19% | 106.57% | 401.07% |
EPS | 0.03 | -0.04 | -0.07 | -0.22 | -0.26 | -0.42 | -0.01 | -0.22 | -0.04 | 0.27 | 0.11 | -0.08 | 0.00 | 0.13 |
EPS Diluted | 0.03 | -0.04 | -0.07 | -0.22 | -0.26 | -0.42 | -0.01 | -0.22 | -0.04 | 0.27 | 0.11 | -0.08 | 0.00 | 0.13 |
Weighted Avg Shares Out | 57.73M | 54.20M | 45.61M | 39.19M | 39.17M | 39.34M | 5.06M | 5.05M | 4.60M | 4.45M | 4.16M | 4.19M | 0.00 | 4.19M |
Weighted Avg Shares Out (Dil) | 57.73M | 54.20M | 45.61M | 39.19M | 39.17M | 39.34M | 5.06M | 5.05M | 4.60M | 4.45M | 4.16M | 4.19M | 0.00 | 4.19M |
Source: https://incomestatements.info
Category: Stock Reports